MoonLake Immunotherapeutics
MLTX
MLTX
45 hedge funds and large institutions have $113M invested in MoonLake Immunotherapeutics in 2021 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 12 closing their positions.
Holders
45
Holders Change
+2
Holders Change %
+4.65%
% of All Funds
0.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
5
Reduced
5
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
![]()
1
Fidelity Investments
Boston,
Massachusetts
|
$11.8M |
2 |
![]()
2
Marshall Wace
London,
United Kingdom
|
$5.27M |
3 |
6CM
3
683 Capital Management
New York
|
$5.84M |
4 |
CS
4
Credit Suisse
Zurich,
Switzerland
|
$3.68M |
5 |
AWG
5
Alpha Wave Global
New York
|
$3.04M |